CHU UCL Namur Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2003
NCT00162812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

CHU-UCL Namur (site Mont-Godinne), Belgium | Clinique Ste Elisabeth - Namur - Belgium | Clinique Ste Elisabeth, Namur, Belgium | UCL Namur